Study for prevention of autoimmune non-insulin-dependent diabetes mellitus with sitagliptin (SPAN-S)
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2017
At a glance
- Drugs Sitagliptin (Primary) ; Pioglitazone
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SPAN-S
- 01 Oct 2017 Results (n=14) published in the Diabetes Therapy.
- 16 Jun 2016 Planned End Date changed from 31 Dec 2020 to 31 Dec 2015.
- 30 Dec 2013 Planned End Date changed from 31 Dec 2018 to 31 Dec 2020 as reported by University Hospital Medical Information Network - Japan.